Essex Investment Management Co. LLC reduced its stake in inTEST Co. (NYSE:INTT – Free Report) by 10.4% in the 4th quarter, HoldingsChannel reports. The firm owned 22,784 shares of the company’s stock after selling 2,651 shares during the quarter. Essex Investment Management Co. LLC’s holdings in inTEST were worth $196,000 as of its most recent SEC filing.
Other institutional investors have also recently made changes to their positions in the company. Royce & Associates LP grew its position in inTEST by 9.9% in the 3rd quarter. Royce & Associates LP now owns 1,219,157 shares of the company’s stock valued at $8,900,000 after purchasing an additional 110,078 shares during the period. XTX Topco Ltd bought a new position in shares of inTEST in the third quarter valued at $120,000. CM Management LLC grew its holdings in shares of inTEST by 4.3% during the fourth quarter. CM Management LLC now owns 365,000 shares of the company’s stock valued at $3,135,000 after buying an additional 15,000 shares during the last quarter. Bard Associates Inc. increased its position in shares of inTEST by 5.7% during the fourth quarter. Bard Associates Inc. now owns 210,491 shares of the company’s stock worth $1,808,000 after acquiring an additional 11,321 shares in the last quarter. Finally, JPMorgan Chase & Co. raised its holdings in shares of inTEST by 42.1% in the 3rd quarter. JPMorgan Chase & Co. now owns 37,481 shares of the company’s stock worth $274,000 after acquiring an additional 11,102 shares during the last quarter. Institutional investors and hedge funds own 63.18% of the company’s stock.
Analyst Ratings Changes
A number of research firms have issued reports on INTT. Northland Securities lifted their price target on inTEST from $13.00 to $16.00 and gave the company an “outperform” rating in a research note on Wednesday, January 8th. Northland Capmk raised inTEST from a “hold” rating to a “strong-buy” rating in a research report on Thursday, January 2nd.
inTEST Stock Down 4.1 %
INTT opened at $7.79 on Monday. inTEST Co. has a fifty-two week low of $6.28 and a fifty-two week high of $14.35. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.26 and a quick ratio of 1.38. The company’s 50-day moving average is $8.58 and its 200 day moving average is $7.78. The firm has a market capitalization of $96.40 million, a P/E ratio of 33.87 and a beta of 1.90.
inTEST (NYSE:INTT – Get Free Report) last announced its earnings results on Friday, March 7th. The company reported $0.23 earnings per share for the quarter, topping analysts’ consensus estimates of $0.14 by $0.09. inTEST had a return on equity of 5.31% and a net margin of 2.33%. During the same period in the prior year, the firm posted $0.16 EPS. Research analysts expect that inTEST Co. will post 0.41 earnings per share for the current fiscal year.
inTEST Company Profile
inTEST Corporation provides test and process technology solutions for use in manufacturing and testing in automotive, defense/aerospace, industrial, life sciences, security, and semiconductor markets worldwide. The company operates through three segments: Electronic Test, Environmental Technologies, and Process Technologies.
Read More
- Five stocks we like better than inTEST
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- The Most Important Warren Buffett Stock for Investors: His Own
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- What is a Stock Market Index and How Do You Use Them?
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Want to see what other hedge funds are holding INTT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for inTEST Co. (NYSE:INTT – Free Report).
Receive News & Ratings for inTEST Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for inTEST and related companies with MarketBeat.com's FREE daily email newsletter.